Published in Int J Radiat Oncol Biol Phys on July 15, 2001
Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis. World J Surg Oncol (2017) 1.40
A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Br J Cancer (2004) 0.93
A phase I study of bortezomib in combination with standard 5-fluorouracil and external-beam radiation therapy for the treatment of locally advanced or metastatic rectal cancer. Clin Colorectal Cancer (2010) 0.89
Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer. Br J Cancer (2003) 0.84
CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II. Br J Cancer (2006) 0.82
Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin. Int J Clin Oncol (2005) 0.80
A nurse is suspended. BMJ (1996) 5.93
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet (2000) 5.04
Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet (1997) 4.36
Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med (1998) 4.34
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J Clin Oncol (2002) 4.25
Epidemiological study of sudden and unexpected deaths due to arteriosclerotic heart disease. Circulation (1966) 3.90
Stringent spacing requirements for transcription activation by CRP. Cell (1990) 3.52
Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med (1998) 3.27
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr (2001) 2.98
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature (1996) 2.95
Foetal respiratory movements, electrocortical and cardiovascular responses to hypoxaemia and hypercapnia in sheep. J Physiol (1974) 2.88
Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas (2004) 2.85
A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg (1985) 2.76
A computer analysis of serial interactions in spaced responding. J Exp Anal Behav (1966) 2.34
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut (2002) 2.31
Antibiotic uptake into gram-negative bacteria. Eur J Clin Microbiol Infect Dis (1988) 2.30
A cloned cyanobacterial gene for glutamine synthetase functions in Escherichia coli, but the enzyme is not adenylylated. Proc Natl Acad Sci U S A (1981) 2.26
Assessment of a universal, school-based hepatitis B vaccination program. JAMA (1995) 2.23
Effects of brief counselling among male heavy drinkers identified on general hospital wards. Drug Alcohol Rev (1996) 2.23
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors. Ann Oncol (2005) 2.23
Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol (2001) 2.20
Acute myocardial infarction: can it be a complication of acute organophosphorus compound poisoning? J Postgrad Med (2013) 2.15
Comment of N.O.P.H.N. Field Staff on Seattle and Richmond Reports. Am J Public Health Nations Health (1948) 2.06
Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem (2000) 2.02
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother (1998) 2.00
Function of the distal rectum after low anterior resection for carcinoma. Br J Surg (1992) 1.98
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil. Br J Cancer (2001) 1.95
Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA (1999) 1.92
Musculoskeletal ultrasound training in rheumatology: the Belfast experience. Rheumatology (Oxford) (2005) 1.86
Denosumab: mechanism of action and clinical outcomes. Int J Clin Pract (2012) 1.84
The role of two surface exposed loops in transcription activation by the Escherichia coli CRP and FNR proteins. Nucleic Acids Res (1991) 1.83
The treatment of depression in chronic low back pain: review and recommendations. Pain (1992) 1.79
Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma. Q J Nucl Med Mol Imaging (2011) 1.76
Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. Am Heart J (1999) 1.76
Tropomyosin isoform switching in tumorigenic human fibroblasts. Mol Cell Biol (1986) 1.75
P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res (2001) 1.74
Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br J Clin Pharmacol (1998) 1.72
Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proc Natl Acad Sci U S A (1992) 1.71
The functional subunit of a dimeric transcription activator protein depends on promoter architecture. EMBO J (1994) 1.70
A study on the transcription of the polyoma viral genome. Proc Natl Acad Sci U S A (1970) 1.67
A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trial. Radiother Oncol (1999) 1.67
Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev (2006) 1.66
Predictive validity of the Readiness to Change Questionnaire. Addiction (1993) 1.65
Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain. J Virol (1997) 1.64
Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group. Int J Radiat Oncol Biol Phys (1996) 1.63
Suppression of EMG activity by transcranial magnetic stimulation in human subjects during walking. J Physiol (2001) 1.61
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn (1995) 1.60
Interactions between the Escherichia coli cyclic AMP receptor protein and RNA polymerase at class II promoters. Mol Microbiol (1993) 1.60
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits. Antimicrob Agents Chemother (1999) 1.60
The structure and physiology of gastrointestinal mucus. Adv Exp Med Biol (1982) 1.59
Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol (2005) 1.58
Physiological characteristics of the human pyloric sphincter. Gastroenterology (1973) 1.57
Dosing of cytotoxic chemotherapy: impact of renal function estimates on dose. Ann Oncol (2013) 1.55
Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry (1999) 1.53
p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes' C colon carcinoma. Oncology (2000) 1.52
Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG) Radiother Oncol (1996) 1.50
Audit of the Medical Audit Committee. CMAJ (1986) 1.49
Breast cancer following treatment for Hodgkin's disease: the need for screening in a young population. Australasian Radiation Oncology Lymphoma Group (AROLG) Australas Radiol (1995) 1.48
Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum Mol Genet (2002) 1.47
Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data. Pathology (2015) 1.47
Pathology reporting of breast cancer: trends in 1989-1999, following the introduction of mammographic screening in Western Australia. Pathology (2005) 1.44
Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem (1996) 1.44
Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat Med (1997) 1.43
The efficacy of treatment for malignant epidural spinal cord compression. Australas Radiol (1997) 1.43
Association of maternal IgM concentrations above the median at 15-19 weeks of gestation and early preterm delivery. Lancet (1999) 1.43
The fractional shortening-velocity ratio: validation of a new echocardiographic Doppler method for identifying patients with significant aortic stenosis. J Am Coll Cardiol (1990) 1.43
Invited article: CO2 laser production of fused silica fibers for use in interferometric gravitational wave detector mirror suspensions. Rev Sci Instrum (2011) 1.42
Habitat degradation and fishing effects on the size structure of coral reef fish communities. Ecol Appl (2010) 1.42
Results of external beam radiotherapy in 448 patients with clinically localized adenocarcinoma of the prostate. Aust N Z J Surg (1994) 1.41
An epidemiological study of sudden and unexpected deaths in adults. Medicine (Baltimore) (1967) 1.41
Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniques. Antimicrob Agents Chemother (1992) 1.41
Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease. Crit Care Med (1999) 1.39
Back pain and metastatic spinal disease. Making the diagnosis. Aust Fam Physician (2001) 1.39
Pre-operative chemo-radiotherapy in locally advanced rectal cancer: is this the way of future management? Australas Radiol (1999) 1.38
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol (2003) 1.38
Three-dimensional conformal radiotherapy in the treatment of prostate cancer in Australia and New Zealand: Report on a survey of radiotherapy centres and the proceedings of a consensus workshop. Australas Radiol (2004) 1.38
Pregnancy outcomes and community health: the POUCH study of preterm delivery. Paediatr Perinat Epidemiol (2001) 1.36
What is hemoglobin A1c? An analysis of glycated hemoglobins by electrospray ionization mass spectrometry. Clin Chem (1998) 1.36
Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum (1997) 1.34
'Close shave' in anterior resection. Br J Surg (1990) 1.33
Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem (2008) 1.32
Comparison of promoter activities in Escherichia coli and Pseudomonas aeruginosa: use of a new broad-host-range promoter-probe plasmid. FEMS Microbiol Lett (1990) 1.31
Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J Immunol (1991) 1.30
Abundant synthesis of the transformation-induced protein of neoplastic human fibroblasts, plastin, in normal lymphocytes. Cancer Res (1985) 1.30
Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes (1996) 1.29
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumour site, stage, adjuvant chemotherapy and type of mutation. Eur J Cancer (2000) 1.29
Lower respiratory tract infections in Inuit infants on Baffin Island. CMAJ (2001) 1.28
Low-level exposures to lead: the Sydney lead study. Dev Med Child Neurol (1989) 1.28
Effect of acute moderate changes in PaCO2 on global hemodynamics and gastric perfusion. Crit Care Med (2000) 1.28
Emission of methane from plants. Proc Biol Sci (2009) 1.28
New antiepileptic drugs: comparison of key clinical trials. Epilepsia (1999) 1.27
The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest (1993) 1.25
A complementary DNA oligomer releases a transcription pause complex. J Biol Chem (1983) 1.25
Mast cells in severely T-cell depleted rats and the response to infestation with Nippostrongylus brasiliensis. Immunology (1979) 1.25
Sequence structure and expression of a cloned beta-glucosidase gene from an extreme thermophile. Mol Gen Genet (1988) 1.24
Control of sexually transmitted diseases in Haiti: results and implications of a baseline study among pregnant women living in Cité Soleil Shantytowns. J Infect Dis (1995) 1.23
Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med (1994) 1.22
Muscarinic receptor activation of phosphatidylcholine hydrolysis. Relationship to phosphoinositide hydrolysis and diacylglycerol metabolism. J Biol Chem (1989) 1.22